Think that was from RDGL's social media flunky perhaps anticipating something coming out of 4th RDGL-FDA meeting worthy of a PR? Seemed unlikely to me. Meetings this late in game aren't a great sign. What one wants to hear from FDA is something like: no meeting needed, go ahead and submit IDE upon completion of current animal tests.
News 
Market Data 
Discover 
